240 related articles for article (PubMed ID: 10636260)
1. Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study).
Anderson TJ; Elstein E; Haber H; Charbonneau F
J Am Coll Cardiol; 2000 Jan; 35(1):60-6. PubMed ID: 10636260
[TBL] [Abstract][Full Text] [Related]
2. Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on postprandial endothelial function.
Wilmink HW; Banga JD; Hijmering M; Erkelens WD; Stroes ES; Rabelink TJ
J Am Coll Cardiol; 1999 Jul; 34(1):140-5. PubMed ID: 10400003
[TBL] [Abstract][Full Text] [Related]
3. BANFF: an update.
Anderson T
Can J Cardiol; 1999 Apr; 15 Suppl B():29B-30B. PubMed ID: 10350682
[TBL] [Abstract][Full Text] [Related]
4. Mechanism by which quinapril improves vascular function in coronary artery disease.
Koh KK; Bui MN; Hathaway L; Csako G; Waclawiw MA; Panza JA; Cannon RO
Am J Cardiol; 1999 Feb; 83(3):327-31. PubMed ID: 10072217
[TBL] [Abstract][Full Text] [Related]
5. Acute effects of ACE inhibition on coronary endothelial dysfunction.
Nickenig G; Stäblein A; Wassmann S; Wyen C; Müller C; Böhm M
J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):361-4. PubMed ID: 11967824
[TBL] [Abstract][Full Text] [Related]
6. Effects of quinapril on coronary blood flow in coronary artery disease patients with endothelial dysfunction. TREND Investigators. Trial on Reversing Endothelial Dysfunction.
Schlaifer JD; Wargovich TJ; O'Neill B; Mancini GB; Haber HE; Pitt B; Pepine CJ
Am J Cardiol; 1997 Dec; 80(12):1594-7. PubMed ID: 9416943
[TBL] [Abstract][Full Text] [Related]
7. ACE-inhibition modulates some endothelial functions in healthy subjects and in normotensive type 1 diabetic patients.
Schalkwijk CG; Smulders RA; Lambert J; Donker AJ; Stehouwer CD
Eur J Clin Invest; 2000 Oct; 30(10):853-60. PubMed ID: 11029598
[TBL] [Abstract][Full Text] [Related]
8. Endothelium: a new target for cardiovascular therapeutics.
Deedwania PC
J Am Coll Cardiol; 2000 Jan; 35(1):67-70. PubMed ID: 10636261
[No Abstract] [Full Text] [Related]
9. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.
Mancini GB; Henry GC; Macaya C; O'Neill BJ; Pucillo AL; Carere RG; Wargovich TJ; Mudra H; Lüscher TF; Klibaner MI; Haber HE; Uprichard AC; Pepine CJ; Pitt B
Circulation; 1996 Aug; 94(3):258-65. PubMed ID: 8759064
[TBL] [Abstract][Full Text] [Related]
10. Role of kinins and angiotensin II in the vasodilating action of angiotensin converting enzyme inhibition in rat renal vessels.
Endlich K; Steinhausen M
J Hypertens; 1997 Jun; 15(6):633-41. PubMed ID: 9218183
[TBL] [Abstract][Full Text] [Related]
11. Influence of smoking status on angiotensin-converting enzyme inhibition-related improvement in coronary endothelial function. TREND Investigators. Trial on Reversing Endothelial Dysfunction.
Schlaifer JD; Mancini GB; O'Neill BJ; Pitt B; Haber HE; Pepine CJ
Cardiovasc Drugs Ther; 1999 May; 13(3):201-9. PubMed ID: 10439882
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of bradykinin-induced tissue plasminogen activator release by angiotensin-converting enzyme inhibition.
Labinjoh C; Newby DE; Pellegrini MP; Johnston NR; Boon NA; Webb DJ
J Am Coll Cardiol; 2001 Nov; 38(5):1402-8. PubMed ID: 11691515
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T
Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
[TBL] [Abstract][Full Text] [Related]
14. [Comparative study of the effect of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study].
Eleuteri E
Ital Heart J Suppl; 2000 Jun; 1(6):830-1. PubMed ID: 11204017
[No Abstract] [Full Text] [Related]
15. Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients.
Yavuz D; Koç M; Toprak A; Akpinar I; Velioğlu A; Deyneli O; Haklar G; Akalin S
J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):197-203. PubMed ID: 14608527
[TBL] [Abstract][Full Text] [Related]
16. [Prospects of endothelial dysfunction reversion in patients with congestive heart failure].
Vizir VA; Berezin AE
Klin Med (Mosk); 2000; 78(7):36-9. PubMed ID: 10979640
[TBL] [Abstract][Full Text] [Related]
17. Comparison of amlodipine and quinapril on ambulatory blood pressure and platelet function in hypertension.
Ding YA; Chang SM; Chou TC
J Hum Hypertens; 1995 Aug; 9(8):637-41. PubMed ID: 8523379
[TBL] [Abstract][Full Text] [Related]
18. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effect of enalapril and losartan in conjunction with surgical coronary revascularisation versus revascularisation alone on systemic endothelial function.
Trevelyan J; Needham EW; Morris A; Mattu RK
Heart; 2005 Aug; 91(8):1053-7. PubMed ID: 16020596
[TBL] [Abstract][Full Text] [Related]
20. Effect of ACE inhibition on endothelial dysfunction in patients with chronic heart failure.
Hornig B; Arakawa N; Drexler H
Eur Heart J; 1998 Jul; 19 Suppl G():G48-53. PubMed ID: 9717056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
